Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 2 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 27 Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 7 Multiple Myeloma 7 Lung Neoplasms 7 Melanoma 6 Stomach Neoplasms 5 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Glioma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Tuberous Sclerosis 3 Sarcoma 3 Papillomavirus Infections 3 Ovarian Neoplasms 3 Hematologic Neoplasms 3 Glioblastoma 3 Warts 2 Venous Thromboembolism 2 Thyroid Neoplasms 2 Skin Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Oligodendroglioma 2 Obesity 2 Neoplasms by Site 2 Myasthenia Gravis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cardiotoxicity × 90 days × Clear all

NCT06183437 2026-03-30

STOP-MED CTRCD

University Health Network, Toronto

Phase 4 Recruiting

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡